| AD | Alzheimer’s disease |
| P-ELISA | Paper-based ELISA |
| Aβ42 | β-amyloid peptide 1–42 |
| MCI | Mild cognitive impairment |
| NINCDS-ADRDA | National Institute of Neurological and Communicative Disorders and Stroke AD and Related Disorders Association |
| DSM | Diagnostic and Statistical Manual of the American Psychiatric Association |
| NIA-AA | National Institute on Aging and the Alzheimer’s Association |
| ELISA | Enzyme-linked immunosorbent assay |
| PCR | Polymerase chain reaction |
| POC | Point-of-care |
| SPR | Surface plasmon resonance |
| Aβ | ββrface plpeptide |
| VEGF | Vascular endothelial growth factor |
| NC16A | Noncollagenous 16A |
| LOD | Limit of detection |
| CSF | Cerebrospinal fluid |
| HRP | Horseradish peroxidase |
| IgG | Immunoglobulin G |
| SPES | Screen-printed electrochemical sensors |
| PE | Plasma exchange |
| APOE | Apolipoprotein E |